TDP-43 antibody（Prothena）

N/A

Report date: 2022/12/13 13:22:44

Base Information

Drug NameTDP-43 antibody（Prothena）
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionTAR DNA binding protein 43 modulators
TargetsTAR DNA binding protein 43
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProthena
China Registration ClassN/A

Develop Information

Active CompaniesProthena
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A